Fucosylated N-glycans as early biomarkers of COVID-19 severity.
Paton B, Herrero P, Peraire J, Del Pino A, Chafino S, Martinez-Picado J, Gómez-Bertomeu F, Rull A, Canela N, Suárez M.
Paton B, et al.
Front Immunol. 2023 Jun 5;14:1204661. doi: 10.3389/fimmu.2023.1204661. eCollection 2023.
Front Immunol. 2023.
PMID: 37342334
Free PMC article.